DekaBank Deutsche Girozentrale’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $921K | Hold |
55,000
| – | – | ﹤0.01% | 881 |
|
|
2025
Q1 | $1.29M | Hold |
55,000
| – | – | ﹤0.01% | 805 |
|
|
2024
Q4 | $1.74M | Hold |
55,000
| – | – | ﹤0.01% | 777 |
|
|
2024
Q3 | $1.58M | Hold |
55,000
| – | – | ﹤0.01% | 804 |
|
|
2024
Q2 | $2.25M | Hold |
55,000
| – | – | ﹤0.01% | 742 |
|
|
2024
Q1 | $3.18M | Hold |
55,000
| – | – | 0.01% | 668 |
|
|
2023
Q4 | $3.43M | Hold |
55,000
| – | – | 0.01% | 662 |
|
|
2023
Q3 | $2.15M | Buy |
+55,000
| New | +$2.15M | 0.01% | 722 |
|
|
2023
Q1 | – | Sell |
-50,000
| Closed | -$2.53M | – | 1304 |
|
|
2022
Q4 | $2.53M | Hold |
50,000
| – | – | 0.01% | 672 |
|
|
2022
Q3 | $3.18M | Sell |
50,000
-7,700
| -13% | -$490K | 0.01% | 611 |
|
|
2022
Q2 | $2.55M | Buy |
57,700
+31,000
| +116% | +$1.37M | 0.01% | 672 |
|
|
2022
Q1 | $1.32M | Sell |
26,700
-16,700
| -38% | -$826K | ﹤0.01% | 854 |
|
|
2021
Q4 | $2.04M | Buy |
43,400
+18,700
| +76% | +$878K | 0.01% | 768 |
|
|
2021
Q3 | $824K | Sell |
24,700
-14,000
| -36% | -$467K | ﹤0.01% | 943 |
|
|
2021
Q2 | $2.43M | Sell |
38,700
-12,000
| -24% | -$754K | 0.01% | 678 |
|
|
2021
Q1 | $2.12M | Hold |
50,700
| – | – | 0.01% | 683 |
|
|
2020
Q4 | $2.77M | Sell |
50,700
-11,500
| -18% | -$628K | 0.01% | 594 |
|
|
2020
Q3 | $1.78M | Buy |
+62,200
| New | +$1.78M | 0.01% | 615 |
|
|
2019
Q3 | – | Sell |
-134,000
| Closed | -$3.28M | – | 995 |
|
|
2019
Q2 | $3.28M | Buy |
+134,000
| New | +$3.28M | 0.02% | 519 |
|